Tekla Capital Management’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,955
Closed -$242K 191
2021
Q1
$242K Hold
11,955
0.01% 191
2020
Q4
$324K Sell
11,955
-98,192
-89% -$2.2M 0.01% 194
2020
Q3
$2.04M Hold
110,147
0.08% 156
2020
Q2
$1.96M Hold
110,147
0.07% 162
2020
Q1
$1.01M Hold
110,147
0.05% 176
2019
Q4
$1.89M Hold
110,147
0.07% 154
2019
Q3
$1.15M Hold
110,147
0.05% 155
2019
Q2
$1.72M Sell
110,147
-62,888
-36% -$1.12M 0.07% 138
2019
Q1
$3.17M Sell
173,035
-63,495
-27% -$1.13M 0.13% 118
2018
Q4
$3.94M Sell
236,530
-42,458
-15% -$984K 0.17% 97
2018
Q3
$7.87M Sell
278,988
-38,962
-12% -$1.12M 0.29% 77
2018
Q2
$8.99M Buy
317,950
+34,700
+12% +$1.03M 0.34% 68
2018
Q1
$8.93M Sell
283,250
-27,000
-9% -$853K 0.35% 64
2017
Q4
$9.04M Hold
310,250
0.35% 59
2017
Q3
$8.83M Hold
310,250
0.32% 61
2017
Q2
$8.01M Hold
310,250
0.3% 65
2017
Q1
$7.45M Hold
310,250
0.29% 69
2016
Q4
$5.26M Hold
310,250
0.22% 78
2016
Q3
$7.47M Hold
310,250
0.29% 71
2016
Q2
$8.25M Hold
310,250
0.34% 66
2016
Q1
$8.53M Buy
310,250
+103,000
+50% +$2.48M 0.36% 64
2015
Q4
$6.43M Buy
207,250
+48,868
+31% +$1.48M 0.23% 80
2015
Q3
$4.17M Buy
158,382
+118,382
+296% +$3.96M 0.15% 107
2015
Q2
$1.44M Hold
40,000
0.05% 101
2015
Q1
$1.38M Buy
+40,000
New +$1.45M 0.05% 111

Other funds holding CLLS

Tekla Capital Management's CLLS Position: Q2 2021 in Review

Tekla Capital Management sold out of Cellectis (CLLS) in Q2 2021, closing a stake of 11,955 shares — an estimated $242K sold.

Tekla Capital Management first reported a position in CLLS in Q1 2015 and held it in 25 quarters. The position peaked at $9.04M in Q4 2017. 78 funds tracked by Wall St. Rank hold CLLS as of Q2 2021.

  • Tekla Capital Management reported no remaining Cellectis position as of Q2 2021 after selling out during the quarter.
  • Tekla Capital Management sold 11,955 Cellectis shares in Q2 2021, an estimated $242K.
  • Tekla Capital Management first reported a position in Cellectis in Q1 2015 and held it in 25 quarters.
  • Tekla Capital Management's Cellectis position peaked at $9.04M in Q4 2017.
  • 78 funds tracked by Wall St. Rank held Cellectis as of Q2 2021.

Based on Tekla Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.